Focused Ultrasound Systems Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Focused Ultrasound Systems Market size was valued at USD 309.85 million in 2026 and is anticipated to grow at a 10.07% CAGR from 2027 to 2036, attaining USD 808.8 million by 2036. The industry revenue for 2027 is assessed at USD 336.34 million.
Get more details on this report
Request Free Sample ReportFocused Ultrasound Systems Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 42.34% of the market, supported by advanced healthcare infrastructure, medical technology research investments, and growing adoption of precision-focused, non-invasive therapeutic procedures.
- Europe is the fastest-growing region, driven by expanding clinical research, healthcare modernization, and investments in specialized treatment centers supporting minimally invasive therapies for neurological disorders and cancer.
Segment Momentum
- HIFU systems held a 96.63% market share in 2026, driven by precise targeted treatment, reduced surgical trauma, improved imaging guidance, and growing interest in alternatives to conventional surgery.
- Hospitals accounted for 59.71% of the market in 2026 and are also the fastest-growing end-use segment, supported by specialized infrastructure, imaging capabilities, multidisciplinary teams, and investment in image-guided therapies.
Market Expansion Drivers
- Adoption of focused ultrasound in neurology & oncology.
- Technological enhancements in precision & imaging.
- Expansion into emerging therapeutic applications.
Leading Market Participants
- Major players in the focused ultrasound systems market include Insightec (Israel), GE HealthCare (USA), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), EDAP TMS (France), FUS Instruments (Canada), Chongqing Haifu (China), Profound Medical (Canada), Theraclion (France), Alpinion Medical Systems (South Korea).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 309.85 million
- 2027 Estimated Market Size: USD 336.34 million
- Projected Market Size: USD 808.8 million by 2036
- Growth Forecast: 10.07% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Europe
- Core Revenue Segment: Product (High Intensity Focused Ultrasound (HIFU) Systems) | Application (Clinical Applications) | End Use (Hospitals)
- Emerging Opportunity Segment: Product (High Intensity Focused Ultrasound (HIFU) Systems) | Application (Clinical Applications) | End Use (Hospitals)
Market Growth Drivers and Industry Trends
Adoption of focused ultrasound in neurology & oncology
The increasing adoption of focused ultrasound technologies in neurological and oncology applications is expected to support market growth as healthcare providers seek less invasive approaches to targeted treatment. Focused ultrasound can deliver therapeutic energy to precisely defined tissue regions while reducing the need for conventional surgical intervention in suitable cases. Growing clinical interest in applications such as movement disorder management, tumor treatment, and other neurological procedures is anticipated to encourage broader acceptance of the technology. Increasing awareness of noninvasive treatment alternatives is likely to further strengthen adoption across specialized healthcare settings.
Technological enhancements in precision & imaging
Continuous improvements in targeting accuracy, imaging guidance, treatment planning, and energy delivery are expected to enhance the clinical utility of focused ultrasound systems. Advanced imaging capabilities can enable healthcare professionals to identify treatment areas more precisely and monitor therapeutic effects during procedures, supporting greater procedural control. Improvements in system integration and real-time treatment guidance are also expected to facilitate more consistent clinical workflows. These technological advancements are anticipated to increase confidence in focused ultrasound procedures and support their adoption across a wider range of medical applications.
Expansion into emerging therapeutic applications
The expansion of focused ultrasound beyond established indications is expected to create additional growth opportunities as researchers and healthcare providers investigate its potential across emerging therapeutic areas. Ongoing clinical development is exploring applications involving drug delivery, blood-brain barrier modulation, pain management, and other targeted interventions. The ability to deliver localized therapeutic effects without conventional invasive procedures is encouraging broader investigation of the technology. As clinical evidence develops and additional applications progress toward routine use, the expanding therapeutic scope is expected to contribute to long-term market growth.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Adoption of focused ultrasound in neurology & oncology | 3% | Short term (≤ 2 yrs) | North America; Europe | High | Fast |
| Technological enhancements in precision & imaging | 2.5% | Medium term (2–5 yrs) | Asia Pacific; North America | Medium | Moderate |
| Expansion into emerging therapeutic applications | 2% | Long term (5+ yrs) | Europe; Asia Pacific | Medium | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the focused ultrasound systems market, representing 42.34% of the market. The region’s leading position is supported by advanced healthcare infrastructure, strong investment in medical technology research, and increasing adoption of non-invasive therapeutic procedures. Focused ultrasound systems are gaining attention for their ability to deliver targeted energy to specific tissues, supporting applications across neurological disorders, oncology, and other therapeutic areas. Growing interest in treatment approaches that minimize surgical intervention, reduce recovery time, and improve procedural precision is encouraging healthcare providers to explore focused ultrasound technologies. The region also benefits from established clinical research capabilities, expanding investments in medical device innovation, and increasing collaboration between healthcare institutions and technology developers. Furthermore, the growing emphasis on precision medicine and patient-centered treatment is supporting the development and clinical adoption of advanced ultrasound-based therapeutic systems.
Europe (Fastest-Growing Region)
Europe is expected to register the fastest growth in the focused ultrasound systems market, driven by increasing demand for minimally invasive treatments, expanding clinical research, and continued modernization of healthcare services. The region’s established medical research ecosystem is supporting the evaluation of focused ultrasound for neurological conditions, cancer treatment, and other therapeutic applications. Growing emphasis on reducing procedural complications and improving patient recovery is encouraging interest in non-invasive treatment alternatives. In addition, investments in advanced medical technologies and the expansion of specialized treatment centers are improving the potential for clinical adoption. Collaboration among hospitals, research institutions, and medical technology developers is also contributing to progress in treatment protocols and device capabilities. As healthcare systems increasingly prioritize precision therapies and less invasive interventions, focused ultrasound systems are expected to gain greater recognition across European clinical settings.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Clinical Translation HubThe U.S. market is centered on translating focused ultrasound into established therapeutic pathways, particularly neurology and oncology. Hospitals, device developers, and research institutions are prioritizing clinical evidence, reimbursement readiness, workflow integration, and regulatory support for noninvasive treatment platforms.
Germany 🇩🇪
Precision Therapy AdoptionGermany is emphasizing focused ultrasound applications that complement precision medicine and minimally invasive care. Adoption priorities include clinical validation, integration with advanced imaging infrastructure, and demonstrating procedural value within hospital settings where treatment accuracy and resource efficiency are important considerations.
Japan 🇯🇵
Noninvasive Care IntegrationJapan presents strong relevance for focused ultrasound where noninvasive interventions can support specialized neurological and oncological care. Providers and technology suppliers are likely to emphasize treatment precision, compatibility with sophisticated imaging systems, and practical integration into established hospital workflows.
South Korea 🇰🇷
Advanced Device DeploymentSouth Korea is building market momentum around technologically advanced therapeutic ultrasound platforms, supported by sophisticated medical-device capabilities. Commercial priorities include expanding clinical applications, strengthening physician familiarity with image-guided procedures, and integrating focused ultrasound into digitally enabled treatment environments.
France 🇫🇷
Hospital-Based InnovationFrance is positioning focused ultrasound within hospital-led innovation, particularly for therapies requiring precision and reduced procedural invasiveness. Market priorities include clinical evidence generation, multidisciplinary adoption, and alignment with established healthcare pathways so that specialized ultrasound systems can move beyond research settings.
Italy 🇮🇹
Specialized Therapy UptakeItaly offers opportunities for focused ultrasound systems in specialized centers where noninvasive therapeutic approaches can address selected neurological and oncological indications. Suppliers are likely to focus on clinical training, referral-center adoption, and demonstrating operational benefits that support integration into specialist treatment programs.
Focused Ultrasound Systems Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: High Intensity Focused Ultrasound (HIFU) Systems (Largest & Fastest-Growing Segment)
The high intensity focused ultrasound (HIFU) systems segment accounted for the largest 2026 market share of 96.63% in the product segment and is also expected to grow at the fastest pace during the forecast period. The segment’s dominant position is driven by the expanding use of focused ultrasound technology as a non-invasive or minimally invasive treatment approach across a range of therapeutic applications. HIFU systems enable the precise delivery of focused acoustic energy to targeted tissue, allowing clinicians to treat lesions while limiting damage to surrounding healthy structures. Growing demand for procedures that reduce surgical trauma, recovery time, and hospitalization requirements is supporting the adoption of HIFU-based treatment platforms. In addition, technological improvements in real-time imaging, treatment planning, targeting accuracy, and energy delivery are enhancing the clinical utility of these systems. Increasing interest in alternatives to conventional surgical interventions, together with the expanding use of focused ultrasound for neurological, oncological, and other therapeutic applications, is expected to further strengthen demand for HIFU systems.
Application Segment Analysis: Clinical Applications (Largest & Fastest-Growing Segment)
The clinical applications segment accounted for the largest 2026 market share of 96.24% in the application segment and is also projected to register the fastest growth during the forecast period. The segment’s leading position is supported by the increasing integration of focused ultrasound systems into clinical treatment pathways where precise, image-guided energy delivery can provide an alternative to conventional invasive procedures. HIFU technology is increasingly utilized for therapeutic interventions involving targeted tissue ablation, particularly in areas where minimizing surgical trauma and preserving surrounding structures are important clinical considerations. The growing prevalence of conditions requiring localized treatment, along with rising demand for non-invasive and minimally invasive therapeutic options, is encouraging healthcare providers to adopt focused ultrasound technologies. Advances in imaging guidance, treatment monitoring, and automated targeting are further improving procedural precision and expanding the range of clinical applications. As awareness of focused ultrasound-based therapies increases among healthcare professionals and patients, broader clinical adoption is expected to support sustained segment growth.
End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
The hospitals segment accounted for the largest market share of 59.71% in 2026 in the end-use segment and is also expected to experience the fastest growth during the forecast period. Hospitals represent a key setting for focused ultrasound system adoption because they possess the specialized infrastructure, multidisciplinary clinical teams, imaging capabilities, and procedural facilities required to operate advanced therapeutic platforms. The increasing demand for non-invasive and minimally invasive treatment options is encouraging hospitals to incorporate focused ultrasound into specialized care pathways, particularly for complex conditions requiring precise tissue targeting. Hospitals also benefit from the ability to integrate focused ultrasound procedures with established diagnostic imaging, surgical, oncology, and neurological services, supporting broader utilization across clinical departments. Furthermore, the expansion of advanced healthcare infrastructure, increasing investment in image-guided therapies, and growing emphasis on reducing procedure-related complications and recovery times are expected to strengthen hospital adoption. The increasing availability of trained specialists and improvements in clinical workflow integration are likely to further accelerate the use of focused ultrasound systems in hospital settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | High Intensity Focused Ultrasound (HIFU) Systems, Low Intensity Focused Ultrasound (LIFU) Systems | High Intensity Focused Ultrasound (HIFU) Systems | High Intensity Focused Ultrasound (HIFU) Systems |
| Application | Clinical Applications, Research Applications | Clinical Applications | Clinical Applications |
| End Use | Hospitals, Imaging Centers, Academic and Research Institutes, Others | Hospitals | Hospitals |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Competition in the focused ultrasound systems market is closely tied to demonstrating that technical capabilities translate into safe, reproducible clinical performance. Precision targeting and image-guided therapy integration are particularly consequential because treatment delivery depends on identifying the intended anatomical location, managing tissue exposure, and coordinating imaging with procedural workflows. Clinical evidence remains essential to establish meaningful patient benefits across specific applications, while imaging compatibility and staff training influence implementation feasibility. Transducer acoustic efficiency contributes to controlled energy delivery, but component-level performance alone does not establish clinical superiority. Procedure time reduction offers an additional operational consideration for healthcare providers managing capacity constraints; however, efficiency gains must not compromise treatment accuracy, safety, or outcomes. Manufacturers that substantiate clinical performance while simplifying workflows and maintaining reliable system operation can present a stronger value proposition to healthcare institutions evaluating focused ultrasound technologies.
Prominent players in the focused ultrasound systems market:
- Insightec (Israel)
- GE HealthCare (USA)
- Philips Healthcare (Netherlands)
- Siemens Healthineers (Germany)
- EDAP TMS (France)
- FUS Instruments (Canada)
- Chongqing Haifu (China)
- Profound Medical (Canada)
- Theraclion (France)
- Alpinion Medical Systems (South Korea)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Insightec (Israel) | |||||||
| GE HealthCare (USA) | |||||||
| Philips Healthcare (Netherlands) | |||||||
| Siemens Healthineers (Germany) | |||||||
| EDAP TMS (France) | |||||||
| FUS Instruments (Canada) | |||||||
| Chongqing Haifu (China) | |||||||
| Profound Medical (Canada) | |||||||
| Theraclion (France) | |||||||
| Alpinion Medical Systems (South Korea) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| HistoSonics | October 2025 | HistoSonics closed an oversubscribed USD 250 million growth financing round to accelerate the commercialization of its Edison Histotripsy System, expand international operations, and support new focused ultrasound clinical indications. |
| HistoSonics | August 2025 | An investor group led by K5 Global acquired a majority stake in HistoSonics, valuing the focused ultrasound company at approximately USD 2.25 billion following significant valuation growth from earlier financing rounds. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Focused Ultrasound Systems Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Therapeutic Target | Neurological disorders, Oncology, Uterine disorders, Pain management, Essential tremor and movement disorders, Other therapeutic targets |
| Clinical Specialty | Neurology and neurosurgery, Oncology, Gynecology, Pain medicine, Other clinical specialties |
| Reimbursement Model | Public or government reimbursement, Private insurance reimbursement, Self-pay, Research-funded or non-reimbursed procedures |
Focused Ultrasound Systems Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Clinical Adoption Pathways |
|
| Hospital Procurement Decision Framework |
|
| Treatment Reimbursement Landscape |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the overall size of the focused ultrasound systems market?
What is the projected value of the focused ultrasound systems industry by 2036?
How are precision and imaging advances strengthening adoption of focused ultrasound systems?
How is the expansion of therapeutic applications shaping the focused ultrasound market?
Why do HIFU systems dominate the focused ultrasound systems market?
What makes hospitals the leading end-use segment for focused ultrasound systems?
Why does North America lead the focused ultrasound systems market?
What is driving focused ultrasound systems market growth in Europe?
Who holds a significant market share in the focused ultrasound systems landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook